Acute myocardial infarction and thyroid function: New pathophysiological and therapeutic perspectives

References

• Lloyed-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, . Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
   Google Scholar
• Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, . ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J. 2008;29:2909–45.
   PubMed Web of Science ®Google Scholar
• Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, O'Neill WW, . Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297:43–51.
   PubMed Web of Science ®Google Scholar
• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20.
   PubMed Web of Science ®Google Scholar
• Araskiewicz A, Grajek S, Lesiak M, Prech M, Pyda M, Janus M, . Effect of impaired myocardial reperfusion on left remodelling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention. Am J Cardiol. 2006;98:725–8.
   Google Scholar
• Krumholz HM, Anderson JL, Bachelder BL, Fesmire FM, Fihn SD, Foody JM, . ACC/AHA 2008 performance measures for adults with ST-elevation and non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (writing Committee to Develop Performance Measures for ST-elevation and Non ST-elevation Myocardial Infarction). J Am Coll Cardiol. 2008; 52:2046–99.
   PubMed Web of Science ®Google Scholar
• Dixon JA, Spinale FG. Pathophysiology of myocardial injury and remodelling: implications for molecular imaging. J Nucl Med. 2010;51:102S–6S.
   Google Scholar
• Pfeffer MA. Left ventricular remodelling after acute myocardial infarction. Ann Rev Med. 1995;46:455–66.
   Google Scholar
• Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY, . Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation. 1992;86:426–30.
   PubMedGoogle Scholar
• Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, . Left venticular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long term prognosis. Circulation. 2002; 106: 2351–7.
   PubMed Web of Science ®Google Scholar
• St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, . Cardiovascular death and left ventricular remodelling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation. 1997;96: 3294–9.
   PubMed Web of Science ®Google Scholar
• Wong SP, French JK, Lydon AM, Manda SO, Gao W, Ashton NG, . Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction. Am J Cardiol. 2004;94:1270–5.
   Google Scholar
• Depre C, Vatner SF. Cardioprotection in stunned and hibernating myocardium. Heart Fail Rev. 2007;12:307–17.
   PubMed Web of Science ®Google Scholar
• Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res. 2006;70:297–307.
   PubMed Web of Science ®Google Scholar
• Kitakaze M. How to mediate cardioprotection in ischemic hearts—accumulated evidence of basic research should translate to clinical medicine. Cardiovasc Drugs Ther. 2010; 24:217–23.
   Google Scholar
• Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, . Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005;102:13807–12.
   PubMed Web of Science ®Google Scholar
• Mai W, Janier MF, Allioli N, Quignodon L, Chuzel T, Flamant F, . Thyroid hormone receptor α is a molecular switch of cardiac function between fetal and postnatal life. Proc Natl Acad Sci U S A. 2004;101:10332–7.
   PubMedGoogle Scholar
• Pantos C, Mourouzis I, Cokkinos DV. New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev. 2011;16:79–96.
   Google Scholar
• Pantos C, Mourouzis I, Xinaris C, Papadopoulou-Daifoti Z, Cokkinos D. Thyroid hormone and ‘cardiac metamorphosis’: potential therapeutic implications. Pharmacol Ther. 2008; 118:277–94.
   PubMed Web of Science ®Google Scholar
• Ojamaa K, Kenessey A, Shenoy R, Klein I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab. 2000;279:E1319−24.
   Google Scholar
• Chen YF, Redetzke RA, Said S, Beyer AJ, Gerdes AM. Changes in left ventricular function and remodeling after myocardial infarction in hypothyroid rats. Am J Physiol Heart Circ Physiol. 2010;298:H259–62.
   PubMed Web of Science ®Google Scholar
• Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112:3122–30.
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos AD, . Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg. 2007;32:333–9.
   PubMed Web of Science ®Google Scholar
• Lee YK, Ng KM, Chan YC, Lai WH, Au KW, Ho CY, . Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol. 2010;24:1728–36.
   Google Scholar
• Campbell SE, Gerdes AM. Regional changes in myocyte size during the reversal of thyroid-induced cardiac hypertrophy. J Mol Cell Cardiol. 1988;20:379–87.
   Google Scholar
• Thomas TA, Kuzman JA, Anderson BE, Andersen SM, Schlenker EH, Holder MS, . Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure. Am J Physiol Heart Circ Physiol. 2005;288:H2118–22.
   Google Scholar
• Olivares EL, Marassi MP, Fortunato RS, da Silva AC, Costa-e-Sousa RH, Ara jo IG, . Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology. 2007;148:4786–92.
   PubMedGoogle Scholar
• Pantos C, Mourouzis I, Galanopoulos G, Gavra M, Perimenis P, Spanou D, . Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism. Horm Metab Res. 2010;42:718–24.
   Google Scholar
• Pol CJ, Muller A, Zuidwijk MJ, van Deel ED, Kaptein E, Saba A, . Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition. Endocrinology. 2011;152:669–79.
   PubMed Web of Science ®Google Scholar
• Brent GA. The molecular basis of thyroid hormone action. N Engl J Med. 1994;331:847–53.
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I, Saranteas T, Paizis I, Xinaris C, Malliopoulou V, . Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Basic Res Cardiol. 2005;100:422–32.
   Google Scholar
• Pantos C, Mourouzis I, Xinaris C, Kokkinos AD, Markakis K, Dimopoulos A, . Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling. Eur J Endocrinol. 2007;156:415–24.
   Google Scholar
• Chen YF, Kobayashi S, Chen J, Redetzke RA, Said S, Liang Q, . Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J Mol Cell Cardiol. 2008;44: 180–7.
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I, Markakis K, Tsagoulis N, Panagiotou M, Cokkinos DV. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol. 2008;103:308–18.
   PubMed Web of Science ®Google Scholar
• Gay R, Gustafson TA, Goldman S, Morkin E. Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction. Am J Physiol. 1987;253(2 Pt 2):H341–6.
   Google Scholar
• Gay RG, Graham S, Aguirre M, Goldman S, Morkin E. Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarction. Am J Physiol. 1988;255(4 Pt 2): H801–6.
   Google Scholar
• Pantos C, Mourouzis I, Tsagoulis N, Markakis K, Galanopoulos G, Roukounakis N, . Thyroid hormone at supra-physiological dose optimizes cardiac geometry and improves cardiac function in rats with old myocardial infarction. J Physiol Pharmacol. 2009;60:49–56.
   Google Scholar
• Henderson KK, Danzi S, Paul JT, Leya G, Klein I, Samarel AM. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. Circ Heart Fail. 2009;2:243–52.
   Google Scholar
• Kalofoutis C, Mourouzis I, Galanopoulos G, Dimopoulos A, Perimenis P, Spanou D, . Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction. Mol Cell Biochem. 2010;345:161–9.
   Google Scholar
• Kuzman JA, Gerdes AM, Kobayashi S, Liang Q. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2005;39:841–4.
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I, Saranteas T, Clav G, Ligeret H, Noack-Fraissignes P, . Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: a new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion? Basic Res Cardiol. 2009; 104:69–77.
   PubMed Web of Science ®Google Scholar
• Eckle T, Köhler D, Lehmann R, El Kasmi K, Eltzschig HK. Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning. Circulation. 2008 118:166–75.
   PubMed Web of Science ®Google Scholar
• Makino A, Suarez J, Wang H, Belke DD, Scott BT, Dillmann WH. Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy. Endocrinology. 2009;150:2008–15.
   Google Scholar
• Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC1alpha. Cardiovasc Res. 2008;79:208–17.
   PubMed Web of Science ®Google Scholar
• Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial transition pore opening during myocardial reperfusion: a target for cardioprotection. Cardiovasc Res. 2004;61:372–85.
   PubMed Web of Science ®Google Scholar
• Chen YF, Bathia S, Redetzke RA, Coburn T, Gerdes AM. Thyroid hormone improves left ventricular myocyte remodeling after myocardial infarction in rats. J Card Fail. 2009; 15:S73.
   Google Scholar
• Chilian WM, Wangler RD, Peters KG, Tomanek RJ, Marcus ML. Thyroxine-induced left ventricular hypertrophy in the rat. Anatomical and physiological evidence for angiogenesis. Circ Res. 1985;57:591–8.
   PubMed Web of Science ®Google Scholar
• Tomanek RJ, Connell PM, Butters CA, Torry RJ. Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy. Am J Physiol. 1995;268(1 Pt 2):H419–25.
   Google Scholar
• Tomanek RJ, Busch TL. Coordinated capillary and myocardial growth in response to thyroxine treatment. Anat Rec. 1998;251:44–9.
   Google Scholar
• Breisch EA, White FC, Hammond HK, Flynn S, Bloor CM. Myocardial characteristics of thyroxine stimulated hypertrophy. A structural and functional study. Basic Res Cardiol. 1989;84:345–58.
   Google Scholar
• Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, . Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res. 2004;94:1500–6.
   PubMed Web of Science ®Google Scholar
• Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, . Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005;146:2864–71.
   PubMed Web of Science ®Google Scholar
• Kazmierczak P, Polak A, Mussur M. Influence of preischemic short-term triiodothyronine administration on hemodynamic function and metabolism of reperfused isolated rat heart. Med Sci Monit. 2004;10:BR381–7.
   Google Scholar
• Tse J, Gandhi A, Yan L, He YQ, Weiss HR. Effects of triiodothyronine pretreatment on beta-adrenergic responses in stunned cardiac myocytes. J Cardiothorac Vasc Anesth. 2003;17:486–90.
   Google Scholar
• Novitzky D, Matthews N, Shawley D, Cooper DK, Zuhdi N. Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg. 1991;51:10–6; discussion 16–7.
   Google Scholar
• Yokoyama Y, Novitzky D, Deal MT, Snow TR. Facilitated recovery of cardiac performance by triiodothyronine following a transient ischemic insult. Cardiology. 1992;81:34–45.
   PubMed Web of Science ®Google Scholar
• Holland FW 2nd, Brown PS Jr, Clark RE. Acute severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg. 1992;54:301–5.
   Google Scholar
• Wechsler AS, Kadletz M, Ding M, Abd-Elfattah A, Dyke C. Effects of triiodothyronine on stunned myocardium. J Card Surg. 1993;8(2 Suppl):338–41.
   Google Scholar
• Dyke CM, Ding M, Abd-Elfattah AS, Loesser K, Dignan RJ, Wechsler AS, . Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg. 1993;56: 215–22.
   PubMed Web of Science ®Google Scholar
• Klemperer JD, Zelano J, Helm RE, Berman K, Ojamaa K, Klein I, . Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg. 1995;109:457–65.
   Google Scholar
• Hsu RB, Huang TS, Chen YS, Chu SH. Effect of triiodothyronine administration in experimental myocardial injury. J Endocrinol Invest. 1995;18:702–9.
   Google Scholar
• Liu Q, Clanachan AS, Lopaschuk GD. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts. Am J Physiol. 1998;275 (3 Pt 1):E392–9.
   Google Scholar
• Novitzky D, Human PA, Cooper DK. Effect of triiodothyronine (T3) on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. An experimental study in baboons. J Thorac Cardiovasc Surg. 1988;96:600–7.
   Google Scholar
• Novitzky D, Human PA, Cooper DK. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg. 1988;45:50–5.
   Google Scholar
• Pantos C, Malliopoulou V, Paizis I, Moraitis P, Mourouzis I, Tzeis S, . Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem. 2003; 242:173–80.
   Google Scholar
• Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Moraitis P, Tzeis S, . Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol. 2003;478:53–60.
   Google Scholar
• Halapas A, Lembessis P, Mourouzis I, Pantos C, Cokkinos DV, Sourla A, . Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model. Exp Physiol. 2008;93:237–46.
   Google Scholar
• Venditti P, Agnisola C, Di Meo S. Effect of ischemia-reperfusion on heart mitochondria from hyperthyroid rats. Cardiovasc Res. 2002;56:76–85.
   Google Scholar
• Masullo P, Venditti P, Agnisola C, Di Meo S. Role of nitric oxide in the reperfusion induced injury in hyperthyroid rat hearts. Free Radic Res. 2000;32:411–21.
   PubMed Web of Science ®Google Scholar
• Pavon N, Aranda A, Garcia N, Hernandez-Esquivel L, Chavez E. In hyperthyroid rats octylguanidine protects the heart from reperfusion damage. Endocrine. 2009;35:158–65.
   Google Scholar
• Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction. Is it cardioprotective in patients with angina? Arch Int Med. 2002;162:1388–94.
   Google Scholar
• Kimur T, Kotajima N, Kanda T, Kuwabara A, Fukumura Y, Kobayashi I. Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction. Res Commun Mol Pharmacol. 2001;110:63–58.
   Google Scholar
• Ceremuzynski L, Czerwosz L, Chamiec T, Bartoszewicz Z, Herbaczynska-Cedro K. Low serum triiodotrhyronine in acute myocardial infarction indicates major heart injury. Kardiol Pol. 2004;60:468–80.
   Google Scholar
• Wiersinga WM, Lie KI, Touber JL. Thyroid hormones in acute myocardial infarction. Clin Endocrinol. 1981;14:367–74.
   Google Scholar
• De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999; 84:151–64.
   PubMed Web of Science ®Google Scholar
• Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, . Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708–13.
   PubMed Web of Science ®Google Scholar
• Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, . Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167:1526–32.
   PubMedGoogle Scholar
• Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G, . Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118: 132–6.
   PubMed Web of Science ®Google Scholar
• Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, .; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.
   PubMed Web of Science ®Google Scholar
• Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med. 2000;132:70–8.
   Google Scholar
• Yun KH, Jeong MH, Lee EM, Lee J, Rhee SJ, Yoo NJ, . Relationship of thyroid stimulating hormone with coronary athrosclerosis in angina patients. Int J Cardiol. 2007;122:56–60.
   Google Scholar
• Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L'Abbate A. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol. 2009;32:380–5.
   PubMed Web of Science ®Google Scholar
• Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S. Association between increased levels of reverse T3 and mortality after acute myocardial infarction. Am J Med. 2001; 111: 699–703.
   Google Scholar
• Kocher A. Ueber morbus Basedowi. Mitt Grenzgeb Med Chir. 1901;1:1–13.
   Google Scholar
• Greenfield WS. Autopsy findings in a 58 year old woman with myxoedema. Published as an appendix to Ord WM. Med Chir Trans. 1878;61:57.
   Google Scholar
• Somerville W, Levine SA. Angina pectoris and thyrotoxicosis. Br Heart J. 1950;12:245–57.
   Google Scholar
• The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. JAMA. 1972;220:996–1008.
   PubMed Web of Science ®Google Scholar
• Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R. Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. Am J Physiol. 1990;258:E715–26.
   PubMedGoogle Scholar
• Young WF Jr, Gorman CA, Jiang NS, Machacek D, Hay ID. L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect. Clin Pharmacol Ther. 1984;36:781–7.
   PubMed Web of Science ®Google Scholar
• Jones RJ, Cohen L. Sodium dextro-thyrxine in coronary disease and hypercholesteremia. Circulation. 1961;24;164–70.
   PubMed Web of Science ®Google Scholar
• Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, . Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation. 2006;114:I245–50.
   Google Scholar
• Portman MA, Slee A, Olson AK, Cohen G, Karl T, Tong E, . TRICC Investigators. Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation. 2010;122:S224–33.
   PubMed Web of Science ®Google Scholar
• Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D, . Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008;93:1351–8.
   PubMed Web of Science ®Google Scholar
• Mebis L, van den Berghe G. The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med. 2009;67: 332–40.
   PubMed Web of Science ®Google Scholar
• Liu Y, Redetzke RA, Said S, Pottala JV, de Escobar GM, Gerdes AM. Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am J Physiol Heart Circ Physiol. 2008;294:H2137–43.
   Google Scholar
• Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, . Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab. 2005;90:6498–507.
   PubMed Web of Science ®Google Scholar
• De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, Bandyopadhyay D, . Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol. 2004;182:303–14.
   Google Scholar
• Goldman S, McCarren M, Morkin E, Ladenson PW, Edson R, Warren S, . DITPA (3,5-diiodothyropropionic acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study. Circulation. 2009;119:3093–100.
   PubMed Web of Science ®Google Scholar
• Schultz RL, Swallow JC, Waters RP, Kuzman JA, Redetzke RA, Said S, . Effects of excessive long-term exercise on cardiac function and myocyte remodeling in hypertensive heart failure rats. Hypertension. 2007;50: 410–6.
   PubMed Web of Science ®Google Scholar
• Tribulova N, Knezl V, Shainberg A, Seki S, Soukup T. Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol. 2010;52:102–12.
   PubMed Web of Science ®Google Scholar
• Betsuyaku T, Kanno S, Lerner DL, Schuessler RB, Saffitz JE, Yamada KA. Spontaneous and inducible ventricular arrhythmias after myocardial infarction in mice. Cardiovasc Pathol. 2004;13:156–64.
   Google Scholar
• Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87;1435–41.
   PubMed Web of Science ®Google Scholar
• Manoach M, Tribulova N, Vogelezang D, Thomas S, Podzuweit T. Transient ventricular fibrillation and myosin heavy chain isoform profile. J Cell Mol Med. 2007;11:171–4.
   Google Scholar
• Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, . Thyroid hormones and the cardiovascular system: Pathophysiology and interventions. Biomed Pharmacother. 2009;63:742–53.
   PubMed Web of Science ®Google Scholar
• Maseri A. Forewords. Iervasi G, Pingitore A. Thyroid and heart failure: from pathophysiology to clinics. Milan and New York: Springer; 2009.
   Google Scholar